Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / एक GPC3-लक्ष्यीकरण Bispecific एंटीबॉडी,…
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Cancer Research
एक GPC3-लक्ष्यीकरण Bispecific एंटीबॉडी, GPC3-एस-फैब, शक्तिशाली Cytotoxicity के साथ
Unraveling Key Players of Humoral Immunity: Advanced and Optimized Lymphocyte Isolation Protocol from Murine Peyer's Patches
Journal (Cancer Research)
Unraveling Key Players of Humoral Immunity: Advanced and Optimized Lymphocyte Isolation Protocol from Murine Peyer's Patches
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
Journal (Cancer Research)
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
 
Click here for the English version

एक GPC3-लक्ष्यीकरण Bispecific एंटीबॉडी, GPC3-एस-फैब, शक्तिशाली Cytotoxicity के साथ

Article DOI: 10.3791/57588-v • 11:13 min • July 12th, 2018
July 12th, 2018 •
1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2
1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

यहां, हम ई कोलाई में एक bispecific एंटीबॉडी GPC3-एस-फैब का उत्पादन करने के लिए एक प्रोटोकॉल पेश करते हैं । शुद्ध GPC3-एस फैब GPC3 सकारात्मक जिगर कैंसर की कोशिकाओं के खिलाफ प्रबल cytotoxicity है ।

Tags

कैंसर रिसर्च इश्यू १३७ Bispecific एंटीबॉडी एंटीबॉडी सिंगल डोमेन VHH GPC3-एस-फैब GPC3 लिवर कैंसर
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter